Skip to main content

Critical Illness clinical trials at UCSF

1 research study open to eligible people

Critical illness is a serious medical condition. UCSF has a new trial called "Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery.” Patients with sepsis-induced hypotension can join this trial to try two different treatments: intravenous Vitamin C or intravenous Acetaminophen.

Showing trials for
  • Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery

    open to eligible people ages 18 years and up

    Prospective multi-center phase 2b randomized placebo-controlled double-blinded interventional platform trial of two different pharmacologic therapies (intravenous Vitamin C or intravenous Acetaminophen) for patients with sepsis-induced hypotension or respiratory failure.

    Fresno, California and other locations

Last updated: